Skip to content

Clinical research on the functional remodeling of sarcopenia patients after stroke based on Brunnstrom technique resistance exercise

Clinical research on the functional remodeling of sarcopenia patients after stroke based on Brunnstrom technique resistance exercise

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121987
Enrollment
Unknown
Registered
2026-04-08
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke-associated sarcopenia

Interventions

Conventional rehabilitation group:Regular rehabilitation training: mainly includes proper limb positioning, passive joint range of motion training, active movement induction, and bed-based functional
experimental group:On the basis of the control group, add resistance exercises based on Brunnstrom.

Sponsors

North China University of Science and Technology Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnostic criteria for cerebral infarction and cerebral hemorrhage as stipulated in the "Key Points for Diagnosis of Major Cerebrovascular Diseases in China 2019", and confirmed by CT or MRI examination; 2. Meeting the diagnostic criteria for low muscle mass, low muscle strength and physical function impairment as specified in the "Diagnosis and Treatment Guidelines for Sarcopenia in China 2024 Edition"; 3. Brunnstrom stage of upper limb <= 3; 4. Age ranging from 45 to 89 years old; 5. Stroke duration within 1 to 4 weeks; 6. Patients or their families have signed the informed consent form and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1. Combined with severe functional impairments of important organs such as the heart, liver and kidneys. 2. Has severe cognitive impairment and is unable to cooperate with the treatment. 3. Suffers from other diseases that may cause muscle loss, such as malignant tumors and severe endocrine disorders.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer;Muscle thickness;The strength of the healthy side;Muscle mass;

Secondary

MeasureTime frame
prealbumin;neural functional recovery;activities of daily living;

Countries

China

Contacts

Public ContactXue Xinhong

Affiliated Hospital of North China University of Technology

xxhzxm129@sohu.com+86 153 8305 5517

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026